The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Clopidogrel Taw Pharma

Taw Pharma (Ireland) LtdEU/1/09/559/001-016

Main Information

Trade NameClopidogrel Taw Pharma
Active SubstancesClopidogrel hydrochloride
Dosage FormFilm-coated tablet
Licence HolderTaw Pharma (Ireland) Ltd
Licence NumberEU/1/09/559/001-016

Group Information

ATC CodeB01AC Platelet aggregation inhibitors excl. heparin
B01AC04 clopidogrel


License statusAuthorised
Licence Issued21/09/2009
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0005-028-003
Interchangeable List DocumentPDF of Interchangeable List
« Back